Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Nov 27;26:171. doi: 10.1186/s13058-024-01881-y

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© World Health Organization and the Authors 2024 2024

Open Access This article is licensed under the terms of the Creative Commons Attribution 3.0 IGO License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the WHO, provide a link to the Creative Commons licence and indicate if changes were made. The use of the WHO’s name, except in reference to the article, and the use of the WHO’s logo, is not authorized as part of this licence. The link provided below includes additional terms and conditions of the licence. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/3.0/igo/.

PMC Copyright notice

Fig. 3 — Forest plot of proportion of metastatic recurrences in women diagnosed with a early (I-IIa) and b locally advanced (IIb-IIIc) breast cancer at (i) 1–4 years; (ii) 5–9 years; (iii) 10+ years (locally advanced only) median follow-up

Fig. 3 — Forest plot of proportion of metastatic recurrences in women diagnosed with a early (I-IIa) and b locally advanced (IIb-IIIc) breast cancer at (i) 1–4 years; (ii) 5–9 years; (iii) 10+ years (locally advanced only) median follow-up